» Articles » PMID: 20609096

Prospective Study on Dialysis Patients After Total Parathyroidectomy Without Autoimplant

Overview
Specialty Nephrology
Date 2010 Jul 9
PMID 20609096
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Secondary hyperparathyroidism is common in chronic kidney disease. When medical treatment fails, subtotal or total parathyroidectomy with autoimplant is done but both are associated with a high recurrence rate. The third surgical strategy is total parathyroidectomy without autoimplant. We evaluate the outcomes of patients who had total parathyroidectomy with no autoimplant.

Methods: Thirteen patients who had total parathyroidectomy without autoimplant were prospectively studied from 1998-2002. Intact parathyroid hormone, biochemistry and bone mineral densities were measured at baseline and serially. All patients had bone biopsies done preoperatively and seven had repeat bone biopsies at a mean of 37.7 months postoperatively. Histomorphometric studies were done for all bone biopsies. Patients were observed for fractures.

Results: Five patients were on haemodialysis and eight on peritoneal dialysis. Mean duration of follow up was 68 months. Postoperatively, mean intact parathyroid hormone decreased precipitously and remained within or just above normal. Mean serum calcium phosphate product decreased and remained normal. Out of seven patients who had repeat bone biopsies, two showed reversal of hyperparathyroid bone disease to normal, two had mild hyperparathyroidism, while three had adynamic bone disease. One patient with adynamic bone disease subsequently developed biochemical recurrence of hyperparathyroidism. Serial bone densitometry showed remarkable improvement. There was no fracture.

Conclusion: In the studied series of total parathyroidectomy without autoimplant, adynamic bone disease occurred in three out of seven repeat bone biopsies while improvement occurred in the rest. Bone mineral density was much improved and there was no fracture.

Citing Articles

Analysis of the efficacy of different amounts of parathyroid grafts in the treatment of secondary hyperparathyroidism.

Chen W, Zhou G BMC Endocr Disord. 2024; 24(1):242.

PMID: 39533308 PMC: 11555849. DOI: 10.1186/s12902-024-01777-0.


Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective.

Chandran M, Wong J Indian J Endocrinol Metab. 2019; 23(4):391-399.

PMID: 31741895 PMC: 6844175. DOI: 10.4103/ijem.IJEM_292_19.


Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.

Sumida K, Ubara Y, Hoshino J, Mise K, Hayami N, Suwabe T Osteoporos Int. 2015; 27(4):1441-1450.

PMID: 26525045 DOI: 10.1007/s00198-015-3377-6.


Application of total parathyroidectomy with auto-transplantation for uremia secondary hyperparathyroidism treatment.

Jing Y, Zhao H, Ge Y, Jia F, He Q, Wang S Int J Clin Exp Med. 2015; 8(7):11188-94.

PMID: 26379922 PMC: 4565305.


Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience.

He Q, Zhuang D, Zheng L, Fan Z, Zhou P, Zhu J BMC Surg. 2014; 14:26.

PMID: 24886230 PMC: 4021022. DOI: 10.1186/1471-2482-14-26.